Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q3

3034.TEDINET S100SVU6
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥134.5bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥170.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥126.1bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥5.7bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥6.8bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥6.5bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥10.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥7.1bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥6.5bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥7.1bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥3.8bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥4.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥115.9bnat 2023-12-31Cons.Assets
Total assets¥101.9bnat 2023-03-31Cons.Assets
Total assets¥105.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥64.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥53.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥51.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥48.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥47.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥23.2bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥18.8bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥101.472023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.642023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥152.962022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥112.572022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.432022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio44.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio47.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio44.8%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥373m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥373m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥2.7bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2023-04-01 → 2023-12-31¥123.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2023-04-01 → 2023-12-31¥123.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥76m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2023-04-01 → 2023-12-31¥7.6bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥11.6bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥11.3bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥296m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31¥884m
—segment totalrevenue2023-04-01 → 2023-12-31¥134.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥134.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥373m
—segment totalsegment profit2023-04-01 → 2023-12-31¥8.5bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥317m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥2.6bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-12-31¥115.4bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-12-31¥115.3bn
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥66m
jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.3bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥11.1bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.8bn
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥250m
jpcrp040300-q3r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
—segment totalrevenue2022-04-01 → 2022-12-31¥126.4bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥126.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥317m
—segment totalsegment profit2022-04-01 → 2022-12-31¥9.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Net salesPrior1YTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember115353000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember11065000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember126418000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-317000000JPY
Net salesPrior1YTDDuration126101000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember8275000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember1158000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember9434000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-2593000000JPY
Operating incomePrior1YTDDuration6841000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember123253000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember11274000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember134528000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration134528000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember76000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember296000000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember373000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-373000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember123330000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember11571000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember134901000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-373000000JPY
Net salesCurrentYTDDuration134528000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E03476-000HealthInsurancePharmacyReportableSegmentsMember7593000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E03476-000MedicalRelatedReportableSegmentMember884000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember8478000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-2748000000JPY
Operating incomeCurrentYTDDuration5729000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-02-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第32期第３四半期 (自 2023年10月１日 至 2023年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)クオールホールディングス株式会社
Company name in english cover pageFilingDateInstantQol Holdings Co.,Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 中村 敬
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区虎ノ門四丁目３番１号 城山トラストタワー37階
Telephone number address of registered headquarter cover pageFilingDateInstant03－6430－9060
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経営管理部　部長 緒方 伸一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区虎ノ門四丁目３番１号 城山トラストタワー37階
Telephone number nearest place of contact cover pageFilingDateInstant03－6430－9060
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経営管理部　部長 緒方 伸一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE03476
Fund codeFilingDateInstant－
Security codeFilingDateInstant30340
Filer name in japaneseFilingDateInstant
Original text (Japanese)クオールホールディングス株式会社
Filer name in englishFilingDateInstantQol Holdings Co., Ltd.

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass